Healthtech funding in 2023
European Healthtech startup funding raised during 2023.
In 2023, 509 European Healthtech companies closed 535 funding rounds and raised €7.2B in equity funding (excluding debt and grants). Debt rounds added €300M. Netherlands led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 18 Nov 2026.
Equity funding
€7.2B
excl. debt & grants · +€300M debt
Funding rounds
535
Companies
509
Top country
Netherlands
Healthtech: last three years
change vs the year beforeRank among sectors
#5
9.8% of sector funding
Debt financing
€300M
4.0% of total
Top-10 round share
51.3%
of disclosed capital
Rounds ≥ €100M
11
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2023 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €538M | 66 |
| Feb | €580M | 54 |
| Mar | €517M | 57 |
| Apr | €443M | 45 |
| May | €585M | 47 |
| Jun | €309M | 40 |
| Jul | €279M | 36 |
| Aug | €3.0B | 30 |
| Sep | €391M | 39 |
| Oct | €321M | 44 |
| Nov | €286M | 45 |
| Dec | €251M | 32 |
Top countries
by € raisedHealthtech — top countries by capital, 2023 — interactive chart.
Data table
| Healthtech — top countries by capital, 2023 | |
|---|---|
| Netherlands | €2.8B |
| UK | €1.5B |
| France | €822M |
| Germany | €628M |
| Switzerland | €523M |
| Denmark | €356M |
| Sweden | €189M |
| Belgium | €178M |
Stage mix
by € raisedHealthtech — stage mix, 2023 — interactive chart.
Data table
| Healthtech — stage mix, 2023 | |
|---|---|
| Other | €4.6B |
| Series A | €850M |
| Series B | €695M |
| Series C | €588M |
| Debt | €300M |
| Seed | €250M |
| Series D+ | €123M |
| Grant | €73M |
| Pre-Seed | €37M |
| Early VC | €3.5M |
| Crowdfunding | €3.1M |
| Growth/Late | €1.0M |
Exits & M&A
37 Acquisition · 1 Merger38 exits · €6.6B disclosed.
| Abcam | Acquisition | Aug 2023 | €5.2B |
| MedAlliance | Acquisition | Oct 2023 | €1.1B |
| Verogen | Acquisition | Jan 2023 | €140M |
| Odin Vision | Acquisition | Jun 2023 | €77M |
| Diamond Whites | Acquisition | Feb 2023 | €30M |
Largest equity rounds
by disclosed amount, 2023| Company | Stage | Date | Amount |
|---|---|---|---|
| Philips | Other | Aug 2023 | €2.6B |
| Compass Pathways | Other | Aug 2023 | €261M |
| CMR Surgical | Other | Sep 2023 | €154M |
| DistalMotion | Other | Apr 2023 | €137M |
| Aqemia | Other | Dec 2023 | €129M |
| Amolyt Pharma | Series C | Jan 2023 | €129M |
| Hemab Therapeutics | Series B | Feb 2023 | €127M |
| Ascend | Other | May 2023 | €121M |
| Noema Pharma | Series B | Mar 2023 | €105M |
| Patient21 | Series C | May 2023 | €100M |
Largest debt rounds
debt financing, 2023; not in the equity total| Company | Stage | Date | Amount |
|---|---|---|---|
| Evotec | Debt | Feb 2023 | €150M |
| In Ovo | Debt | Nov 2023 | €40M |
| ExeVir Bio | Debt | Jan 2023 | €25M |
| Inbrain Neuroelectronics | Debt | Dec 2023 | €20M |
| Icosagen | Debt | Feb 2023 | €18M |
Top investors
most active in 2023, by deal count- High-Tech Gründerfonds (HTGF)16 deals
- European Innovation Council (EIC)13 deals
- Bpifrance9 deals
- Octopus Ventures9 deals
- Sofinnova Partners9 deals
- Calm Storm Ventures8 deals
- Innovate UK8 deals
- Novo Holdings7 deals
- BGF6 deals
- Scottish Enterprise6 deals
Source: Tech.eu Funding Explorer · data as of 18 Nov 2026 · licence CC BY 4.0 · Methodology